Uterine Fibroid Treatment Devices Market

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Mode of Treatment
    5.3 Market Evolution
    5.4 Market Dynamics
           5.4.1 Key Market Drivers
           5.4.2 Key Market Restraints
           5.4.3 Key Market Opportunities
           5.4.4 Key Market Challenges

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Uterine Fibroid Treatment Devices Market, By Technology
    7.1 Introduction
    7.2 Surgical Techniques
           7.2.1 Hysterectomy 
           7.2.2 Myomectomy 
    7.3 Laparoscopic Techniques
           7.3.1 Laparoscopic Myomectomy 
           7.3.2 Myolysis 
    7.4 Ablation Techniques 
           7.4.1 Microwave Ablation 
           7.4.2 Hydrothermal Ablation 
           7.4.3 Cryoablation
           7.4.4 Ultrasound Ablation 
                    7.4.4.1 High-Intensity Focused Ultrasound (HIFU)  
                    7.4.4.2 MRI-Guided Focused Ultrasound (MRGFUS)
           7.4.5 Other Ablation Techniques*
    7.5 Embolization Techniques

8 Uterine Fibroid Treatment Devices Market, By Mode of Treatment
    8.1 Introduction
    8.2 Invasive Treatment 
    8.3 Minimally Invasive Treatment 
    8.4 Non-Invasive Treatment 

9 Uterine Fibroid Treatment Devices Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 Italy
           9.3.3 France
           9.3.4 U.K.
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific (ROAPAC)
    9.5 Rest of the World (RoW)

10 Competitive Landscape
     10.1 Introduction
     10.2 Market Share Analysis, By Key Players (2014)
     10.3 Competitive Scenario
     10.4 Recent Developments
             10.4.1 New Products Launches and Product Enhancements
             10.4.2 Agreements, Partnerships, and Agreements
             10.4.3 Mergers and Acquisitions
             10.4.4 Geographic Expansions
             10.4.5 Other Developments

11 Compny Profiles*
     11.1 Introduction
     11.2 Advanced Surgical Concepts  
             11.2.1 Business Overview**
             11.2.2 Financial Overview
             11.2.3 Product Portfolio
             11.2.4 Recent Developments
     11.3 Boston Scientific Corporation  
     11.4 Conmed Corporation
     11.5 Coopersurgical, Inc.
     11.6 Ethicon, Inc.
     11.7 Hologic, Inc.
     11.8 Medtronic, PLC.
     11.9 Olympus Corporation
     11.10 Pentax Medical
     11.11 Stryker Corporation

12 Appendix
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Introducing RT: Real Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.